Insider Trading & Ownership of Barbara Klencke

Location: Pasadena, CA
Summary: The estimated net worth of Barbara Klencke is at least $801,452 dollars as of 05 Mar 2026. Barbara Klencke is the Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $370.3K. Barbara Klencke is the Chief Medical Officer of ALX ONCOLOGY HOLDINGS INC and owns shares of ALX ONCOLOGY HOLDINGS INC (ALXO) stock worth about $224.4K. Barbara Klencke is the Director of Xencor Inc and owns shares of Xencor Inc (XNCR) stock worth about $206.8K.
Signature: /s/ Shelly Pinto, by power of attorney
All Insider Reports: All Insider Reports

Notify me when Barbara Klencke files a new Insider Trading report.

Ownership of Barbara Klencke

Symbol	Company	Relationship	Holdings Value	Report Period
TCRX	TScan Therapeutics, Inc.	Director	$370,300	30 Jun 2025
ALXO	ALX ONCOLOGY HOLDINGS INC	Chief Medical Officer	$224,400	03 Mar 2026
XNCR	Xencor Inc	Director	$206,752	12 Jun 2025
EFTR	eFFECTOR Therapeutics, Inc.	Director		13 Jun 2024
SRRA	Sierra Oncology, Inc.	Chief Medical Officer		01 Jul 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.